Spectrum Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.12.17	Spectrum Pharmaceuticals Highlights 15 Abstracts at the 59th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Georgia, December 9-12, 2017 (Businesswire)
08.11.17	Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2017 London Healthcare Conference on November 15th (Businesswire)
02.11.17	Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results and Pipeline Update (Businesswire)
30.10.17	Spectrum Pharmaceuticals Announces Initiation of a Multicenter Phase 2 Trial of Poziotinib in Non-Small Cell Lung Cancer (NSCLC) Patients with Exon 20 Insertion Mutation in EGFR or HER2 (Businesswire)
19.10.17	SPPI Breathes Easy On Trial Results, PTI Awaits Data In Q4, HAIR Keeps Receding (RTTNews)
18.10.17	Spectrum Pharmaceuticals Remains Sharply Higher After Initial Jump (RTTNews)
29.09.17	PTCT's Quest For Approval Of DMD Drug Translarna (RTTNews)
29.09.17	DXCM Falls On CGM Rivalry, ZYNE Firms Up, SPPI In Limelight, Big Day Awaits MNKD (RTTNews)
28.09.17	Gainers & Losers Of Sep.27: ADXS, BGNE, CDXS, VSAR, ITCI... (RTTNews)
21.08.17	Breakfast Technical Briefing on Biotech Stocks -- Kite Pharma, Novavax, Sangamo Therapeutics, and Spectrum Pharma (PR Newswire)
01.08.17	Spectrum Pharmaceuticals Announces Completion of Enrollment in the Phase 3 Pivotal Study (ADVANCE) of ROLONTIS™ (eflapegrastim), a Novel Long-Acting GCSF (Businesswire)
04.05.17	Gainers & Losers Of May 3: PIRS, MYGN, XENT, RXDX, SPPI... (RTTNews)
10.04.17	Research Reports Initiation on Biotech Stocks -- La Jolla Pharma, Spectrum Pharma, Advaxis, and Aevi Genomic (PR Newswire)
02.02.17	Research Reports Coverage on Biotech Stocks -- Anavex Life Sciences, Omeros, Spectrum Pharma, and Lexicon Pharma (PR Newswire)
29.12.16	Research Reports Initiation on Biotech Stocks -- Incyte, Anavex Life Sciences, Portola Pharma, and Spectrum Pharma (PR Newswire)
21.11.16	TENX Awaits Data In Jan, GBIM Hit Hard, FDA Says No To SPPI (RTTNews)
18.11.16	SPPI UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of November 21, 2016 (PR Newswire)
17.11.16	Spectrum Pharmaceuticals Announces Poziotinib Data Presentation at the 17th IASLC World Conference on Lung Cancer in Vienna, Austria, December 4-7, 2016 (Businesswire)
15.09.16	Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz (RTTNews)
30.08.16	Biotech Stocks Facing FDA Decision In September (RTTNews)
20.04.16	Spectrum Pharma Receives FDA Orphan Drug Exclusivity For EVOMELA - Quick Facts (RTTNews)
16.03.16	Abbott's Stent Gets Panel Nod, OPXA Awaits Data In Q4, It's A Yes For SPPI (RTTNews)
15.03.16	Spectrum Pharma: EVOMELA Receives FDA Approval For Two Indications - Quick Facts (RTTNews)
22.02.16	FDA Expands Use Of Pfizer's Ibrance, Attack On Titan, Spectrum Gets FDA Date (RTTNews)
06.12.15	Spectrum Pharmaceuticals and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-Cell Lymphoma in Combination of Belinostat (Beleodaq®) and Standard CHOP (Businesswire)
23.10.15	FDA Snubs SPPI, OCUL Feels Pressure, It's Thumbs Up For MACK, But With Rider (RTTNews)
23.10.15	Spectrum Pharma Receives FDA Response Letter For EVOMELA - Quick Facts (RTTNews)
30.03.15	Spectrum Pharma Says EVOMELA Stability Shown To Be Significantly Longer (RTTNews)
10.03.15	ACRX Plunges On Zalviso News, CTIC Persists, HTBX On Fire, PIP Cuts Head Count (RTTNews)
09.03.15	Spectrum Says FDA Accepts NDA For CE-Melphalan (RTTNews)
26.12.14	Spectrum Pharma Submits NDA For CE-Melphalan (RTTNews)
26.12.14	Spectrum Pharma Submits NDA For CE-Melphalan - Quick Facts (RTTNews)
12.11.14	Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2014 Global London Healthcare Conference on November 19th (Businesswire)
18.09.14	CASI Pharma Gets Exclusive Rights To Certain Spectrum Pharma's Drugs (RTTNews)
16.09.14	Spectrum Pharma's Beleodaq Gets New Patent Extension - Quick Facts (RTTNews)
09.09.14	Spectrum Pharma Meets Primary Endpoint In Phase 2 Study Of Long Acting GCSF (RTTNews)
07.07.14	Spectrum Pharma Gets FDA's Accelerated Approval For T-Cell Cancer Drug Beleodaq (RTTNews)
28.05.14	Spectrum Pharma Completes Enrollment In Phase 2 Study Of SPI-2012 - Quick Facts (RTTNews)
23.04.14	Spectrum Pharma's Trial Of Captisol-Enabled Melphalan Meets Primary Endpoint (RTTNews)
21.04.14	Spectrum Says Promotes Joseph Turgeon To President, COO (RTTNews)
06.02.14	Spectrum Pharma Reports FDA Acceptance Of NDA Filing For Beleodaq For Injection (RTTNews)
18.12.13	Spectrum Pharma Announces Pricing Of $100 Mln Convertible Senior Notes Due 2018 (RTTNews)
11.12.13	Spectrum Says Data From Marqibo, Folotyn Encouraging - Quick Facts (RTTNews)
11.12.13	AVNR's PRIME Flops, BG Medicine Tastes Sweet, CYTR Awaits Data, ENTA Shines (RTTNews)
30.10.13	Spectrum Reports Completion Of Enrollment For Melphalan Pivotal Trial (RTTNews)
08.10.13	Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. (PR Newswire)
04.09.13	RMTI Awaits CRUISE-2, AVNR On A High, ENTA Gets More Funds, Watch Out For ZLCS (RTTNews)
03.09.13	Spectrum Pharma Introduces Marqibo & Ships First Commercial Orders (RTTNews)
29.07.13	Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope (PR Newswire)
29.07.13	Arena Pharma, Geron, Incyte, and Spectrum Pharma Under AAAResearchReports.com Microscope (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.32	1.80 %	K V
UBS Group	28.07	1.45 %	K V
Part Grp Hldg	1’267.00	1.04 %	K V
Swiss Re	129.80	0.85 %	K V
ABB	49.43	0.84 %	K V
Alcon	78.06	0.08 %	K V
Geberit	524.00	0.04 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.15	-0.62 %	K V
Sonova Hldg	301.50	-0.82 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Spectrum Pharmaceuticals IncShs

Aktien Top/Flop

Meistgelesene Nachrichten